92 related articles for article (PubMed ID: 2274756)
1. Renal transplantation in patients with systemic lupus erythematosus: increased risk of early graft loss.
Nyberg G; Karlberg I; Svalander C; Hedman L; Blohmé I
Scand J Urol Nephrol; 1990; 24(4):307-13. PubMed ID: 2274756
[TBL] [Abstract][Full Text] [Related]
2. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
3. Outcome of renal transplantation in ninety-seven cyclosporine-era patients with systemic lupus erythematosus and matched controls.
Stone JH; Amend WJ; Criswell LA
Arthritis Rheum; 1998 Aug; 41(8):1438-45. PubMed ID: 9704643
[TBL] [Abstract][Full Text] [Related]
4. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
[TBL] [Abstract][Full Text] [Related]
5. Kidney transplantation in lupus patients: a case-control study from a single centre.
Lionaki S; Kapitsinou PP; Iniotaki A; Kostakis A; Moutsopoulos HM; Boletis JN
Lupus; 2008 Jul; 17(7):670-5. PubMed ID: 18625640
[TBL] [Abstract][Full Text] [Related]
6. Renal graft survival in children with early acute rejection.
Muñoz R; Romero B; Medeiros M; Zaragoza L
Pediatr Transplant; 1998 Nov; 2(4):294-8. PubMed ID: 10084732
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results.
Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M;
Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208
[TBL] [Abstract][Full Text] [Related]
8. The effects of HLA mismatching and immunosuppressive therapy on early rejection outcome in pediatric heart transplant recipients.
Herzberg GZ; Rossi AF; Courtney M; Gelb BD
J Heart Lung Transplant; 1998 Dec; 17(12):1195-200. PubMed ID: 9883760
[TBL] [Abstract][Full Text] [Related]
9. The LifeLink Foundation and cadaver kidney transplantation in Tampa.
LeFor WM; Wright CE; Bowers VD; Heinrichs DF; Shires DL
Clin Transpl; 1999; ():149-58. PubMed ID: 11038633
[TBL] [Abstract][Full Text] [Related]
10. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
11. Rejection after simultaneous pancreas-kidney transplantation.
Arbogast H; Malaise J; Illner WD; Tarabichi A; Dieterle C; Landgraf R; Land W;
Nephrol Dial Transplant; 2005 May; 20 Suppl 2():ii11-7, ii62. PubMed ID: 15814544
[TBL] [Abstract][Full Text] [Related]
12. Renal transplantation in patients with lupus nephritis: a single-center experience.
Ghafari A; Etemadi J; Ardalan MR
Transplant Proc; 2008; 40(1):143-4. PubMed ID: 18261571
[TBL] [Abstract][Full Text] [Related]
13. Clinical and socioeconomic benefits of serological HLA-DR matching for renal transplantation over three eras of immunosuppression regimens at a single unit.
Taylor CJ; Welsh KI; Gray CM; Bunce M; Bayne AM; Sutton PM; Gray DW; Ting A; Morris PJ
Clin Transpl; 1993; ():233-41. PubMed ID: 7918156
[TBL] [Abstract][Full Text] [Related]
14. Outcome of renal transplantation in patients with systemic lupus erythematosus.
Deegens JK; Artz MA; Hoitsma AJ; Wetzels JF
Transpl Int; 2003 Jun; 16(6):411-8. PubMed ID: 12819872
[TBL] [Abstract][Full Text] [Related]
15. The UNOS Scientific Renal Transplant Registry--ten years of kidney transplants.
Cecka JM
Clin Transpl; 1997; ():1-14. PubMed ID: 9919387
[TBL] [Abstract][Full Text] [Related]
16. [Completely reversed acute rejection episodes do not influence the long-term renal allograft survival].
Wu JY; Chen JH; Wang YM; Zhang JG; Zhu C; Wang SY; Zhang P; Huang HF; He Q
Zhonghua Yi Xue Za Zhi; 2003 Jan; 83(2):106-9. PubMed ID: 12812676
[TBL] [Abstract][Full Text] [Related]
17. [Results, over a 3-year, period of a triple combination: cyclosporin, azathioprine, prednisolone in high-risk kidney transplants].
Hiesse C; Rieu P; Neyrat N; Charpentier B; Benoit G; Bellamy J; Fries D
Nephrologie; 1987; 8(3):127-9. PubMed ID: 3309700
[TBL] [Abstract][Full Text] [Related]
18. Renal outcome and evolution of disease activity in Chinese lupus patients after renal transplantation.
Yu TM; Chen YH; Lan JL; Cheng CH; Chen CH; Wu MJ; Shu KH
Lupus; 2008 Jul; 17(7):687-94. PubMed ID: 18625644
[TBL] [Abstract][Full Text] [Related]
19. Living donor kidney transplantation: the effects of donor age and gender on short- and long-term outcomes.
Øien CM; Reisaeter AV; Leivestad T; Dekker FW; Line PD; Os I
Transplantation; 2007 Mar; 83(5):600-6. PubMed ID: 17353781
[TBL] [Abstract][Full Text] [Related]
20. Immunosuppression in live-related donor renal transplantation.
Iman A; Rao M; Juneja R; Jacob CK
Natl Med J India; 2001; 14(2):75-80. PubMed ID: 11396322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
